Newsfeeds - Spark Newswire

6 minute read

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck’s Keytruda On Track For More Label Expansions, Eliem Debuts

Today, 1:04 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9)

ACET

9 minute read

Stocks That Hit 52-Week Highs On Monday

By Benzinga Insights

Today, 1:04 PM

This morning 113 companies reached new 52-week highs.

1 minute read

Morgan Stanley Maintains Overweight on Axonics, Raises Price Target to $74

By Benzinga Newsdesk

Today, 1:04 PM

Morgan Stanley maintains Axonics (NASDAQ:AXNX) with a Overweight and raises the price target from $62 to $74.

AXNX

1 minute read

Barclays Maintains Overweight on Axonics, Raises Price Target to $79

By Benzinga Newsdesk

Today, 1:04 PM

Barclays analyst Gena Wang maintains Axonics (NASDAQ:AXNX) with a Overweight and raises the price target from $74 to $79.

AXNX

34 minute read

Earnings Scheduled For August 5, 2021

By Benzinga Insights

Today, 1:04 PM

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.

AAOI

6 minute read

The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly’s Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business

By Shanthi Rexaline

Today, 1:04 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2)

ABSI

12 minute read

Stocks That Hit 52-Week Highs On Friday

By Benzinga Insights

Today, 1:04 PM

On Friday morning, 154 companies achieved new highs for the year.

6 minute read

The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam’s Clinical Collaboration, 4 IPOs

By Shanthi Rexaline

Today, 1:04 PM

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29)

ABBV

1 minute read

Barclays Initiates Coverage On Axonics with Overweight Rating, Announces Price Target of $74

By Benzinga Newsdesk

Today, 1:04 PM

Barclays analyst Travis Steed initiates coverage on Axonics (NASDAQ:AXNX) with a Overweight rating and announces Price Target of $74.

AXNX

5 minute read

The Daily Biotech Pulse: Sanofi Bets Big On mRNA Tech, Decision Day For MediWound, DiaMedica Issues Kidney Disease Data Readout

By Shanthi Rexaline

Today, 1:04 PM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 28)

ABUS